Scinovex
reviewTop 1% cited

MicroRNA-Cancer Connection: The Beginning of a New Tale

Cancer Research · 2006 · Vol. 66(15) · pp. 7390–7394
George A. CalinCarlo M. Croce

Abstract

Cancer initiation and progression can involve microRNAs (miRNA), which are small noncoding RNAs that can regulate gene expression. Their expression profiles can be used for the classification, diagnosis, and prognosis of human malignancies. Loss or amplification of miRNA genes has been reported in a variety of cancers, and altered patterns of miRNA expression may affect cell cycle and survival programs. Germ-line and somatic mutations in miRNAs or polymorphisms in the mRNAs targeted by miRNAs may also contribute to cancer predisposition and progression. We propose that alterations in miRNA genes play a critical role in the pathophysiology of many, perhaps all, human cancers.

MicroRNA in disease regulationCancer-related molecular mechanisms researchCircular RNAs in diseasesmicroRNABiologyCancerGeneSomatic cellGene expressionRegulation of gene expressionGeneticsCancer researchBioinformatics

MeSH terms

AnimalsHumansMutationNeoplasmsNucleotide MappingGenetic Predisposition to DiseaseMicroRNAs
Citations
1,060
FWCI
31.35
field-weighted impact
References
40
Percentile
100%
vs. same field & year
Citations per year
Cited by
miR-15a and miR-16-1 in cancer: discovery, function and future perspectives
Cell Death and Differentiation · 2009 · 640 citations
MicroRNA signatures in human cancers
Nature reviews. Cancer · 2006 · 7,589 citations
Noncoding RNA therapeutics — challenges and potential solutions
Nature Reviews Drug Discovery · 2021 · 1,517 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.